Biomarker‐informed model‐based risk assessment of organic anion transporting polypeptide 1B mediated drug‐drug interactions

E Kimoto, C Costales, MA West, Y Bi… - Clinical …, 2022 - Wiley Online Library
Quantitative prediction of drug‐drug interactions (DDIs) involving organic anion transporting
polypeptide (OATP) 1B1/1B3 inhibition is limited by uncertainty in the translatability of …

Biomarker‐Informed Model‐Based Risk Assessment of Organic Anion Transporting Polypeptide 1B Mediated Drug‐Drug Interactions.

E Kimoto, C Costales, MA West, Y Bi… - Clinical …, 2022 - search.ebscohost.com
Quantitative prediction of drug‐drug interactions (DDIs) involving organic anion transporting
polypeptide (OATP) 1B1/1B3 inhibition is limited by uncertainty in the translatability of …

Biomarker-Informed Model-Based Risk Assessment of Organic Anion Transporting Polypeptide 1B Mediated Drug-Drug Interactions

E Kimoto, C Costales, MA West… - Clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
Quantitative prediction of drug-drug interactions (DDIs) involving organic anion transporting
polypeptide (OATP) 1B1/1B3 inhibition is limited by uncertainty in the translatability of …

Biomarker‐Informed Model‐Based Risk Assessment of Organic Anion Transporting Polypeptide 1B Mediated Drug‐Drug Interactions

E Kimoto, C Costales, MA West, Y Bi… - Clinical Pharmacology …, 2021 - cir.nii.ac.jp
抄録< jats: p> Quantitative prediction of drug‐drug interactions (DDIs) involving organic
anion transporting polypeptide (OATP) 1B1/1B3 inhibition is limited by uncertainty in the …

Biomarker-Informed Model-Based Risk Assessment of Organic Anion Transporting Polypeptide 1B Mediated Drug-Drug Interactions.

E Kimoto, C Costales, MA West, YA Bi… - Clinical …, 2021 - europepmc.org
Quantitative prediction of drug-drug interactions (DDIs) involving organic anion transporting
polypeptide (OATP) 1B1/1B3 inhibition is limited by uncertainty in the translatability of …